| 77.40 Real-Time Quote |  -1.08 / -1.38%Today’s Change | 38.44 Today|||52-Week Range 87.47 | +84.73% Year-to-Date |
| 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com |
| Previous close | 78.48 |
| Today’s open | 78.26 |
| Day’s range | 76.73 - 78.40 |
| Volume | 526,007 |
| Average volume (3 months) | 2,533,522 |
| Market cap | $17.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -457.14% |
| Earnings growth (this year) | -244.17% |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +8.25% |
| P/E ratio | NM |
| Price/Sales | 5.82 |
| Price/Book | 17.07 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACTActavis Inc | -1.66 | -1.30% |
| SHPGShire PLC | +1.52 | +1.57% |
| ZTSZoetis Inc | +0.25 | +0.76% |
| ALXNAlexion Pharmaceutic... | -1.80 | -1.80% |
| Next reporting date | July 29, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | -$107.0M |
| Net profit margin | -7.01% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Jeff M. Leiden, PhD, MD |
Chief Financial Officer & Executive Vice President Ian F. Smith, CPA |
Corporate headquarters Cambridge, Massachusetts |
.
